Elicio Therapeutics
ELTX
ELTX
18 hedge funds and large institutions have $2.78M invested in Elicio Therapeutics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less capital invested
Capital invested by funds: $2.8M → $2.78M (-$18.6K)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$287K | |
| 2 | +$137K | |
| 3 | +$137K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$16.7K |
| 5 |
BlackRock
New York
|
+$7.65K |
Top Sellers
| 1 | -$254K | |
| 2 | -$172K | |
| 3 | -$125K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$18.4K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$4.44K |